Novavax says its protein-based Covid vaccine is 80% effective in young adolescents

Novavax says its protein-based Covid vaccine is 80% effective in young adolescents - The latest study enrolled 2,247 children from US, aged 12 to 17. It found the vaccine was 80% effective at preventing symptomatic Covid-19 infection.

Related Keywords

Mexico ,United States ,United Kingdom ,Britain , ,Drug Administration ,World Health Organisation ,World Health ,Novavax ,Covid 19 Vaccine ,Protein ,Hepatitisb Vaccine ,World Health Organisation Who ,Covid 19 Vaccine For Children ,Delta Variant Covid 19 ,Omicron Variant ,Us Food And Drug Administration Fda ,